An older client with heart failure (HF), coronary artery disease (CAD), and hypertension (HTN), is receiving atenolol, furosemide, and enalapril daily. Which assessment(s) should the nurse include in evaluating the effectiveness of the medications? Select all that apply.

A. Range of motion: Range of motion assessments are important for clients with musculoskeletal or joint issues but are not direct indicators of the effectiveness of cardiovascular medications like atenolol, furosemide, and enalapril. Thus, it is not a primary focus for evaluating treatment success in this case. B. Blood pressure: Atenolol and enalapril both help lower blood pressure, and monitoring it is critical to ensure hypertension is controlled. Blood pressure assessment provides direct feedback about the effectiveness of the client's antihypertensive therapy and helps prevent complications such as stroke or heart failure progression. C. Heart sounds: Evaluating heart sounds can reveal new or worsening murmurs, gallops, or signs of fluid overload such as an S3 heart sound, all of which can indicate worsening heart failure. Heart sound assessment helps monitor the effectiveness of heart failure management strategies. D. Daily weight: Daily weights are crucial for clients with heart failure to detect fluid retention early. Furosemide is prescribed to reduce fluid overload, and sudden increases in weight may signal worsening heart failure despite therapy, making this a vital monitoring parameter. E. Bowel sounds: Bowel sounds are not directly affected by atenolol, furosemide, or enalapril. While monitoring bowel function is important for general care, it is not relevant to evaluating the effectiveness of cardiovascular medications in managing heart failure, hypertension, or coronary artery disease.